Michael A. Barry

Mayo Clinic — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

56h-index12.8kcitations291works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(122), Viral Infectious Diseases and Gene Expression in Insects(65), RNA Interference and Gene Delivery(38), Viral gastroenteritis research and epidemiology(35), CAR-T cell therapy research(30)

Publications291 total

mRNA Therapy for Alport Syndrome
2026Open Access
Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence
Proceedings of the National Academy of Sciences·2025Open Access
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease
Kidney360·2025Open Access
Involvement of a tick-borne orthomyxovirus matrix protein in vRNP nuclear export
Journal of Virology·2025Open Access
Therapeutic in situ CAR T cells in genetically humanized HLA DQ8 mouse models 4607
The Journal of Immunology·2025Open Access
Mitigating off target B cell transduction during in situ CAR T cell induction 3591
The Journal of Immunology·2025Open Access
Lung-targeted Lipid Nanoparticle Delivery of a Matricellular mRNA Promotes Fibrotic Lung Repair
American Journal of Respiratory Cell and Molecular Biology·2025· 1 cited
Infection-sensing minigenome as a novel therapeutic approach against Ebola virus
Molecular Therapy — Nucleic Acids·2025Open Access
LYOPHILIZATION OF ADENO-ASSOCIATED VIRUS/MATRIX COMPOSITE ENHANCES TRANSGENE EXPRESSION WITHIN OSSEOUS DEFECTS LEADING TO IMPROVED HEALING
Orthopaedic Proceedings·2025
PERSISTENT EXPRESSION OF CHITINASE 3-LIKE 1 IN EX VIVO-MAINTAINED GLIOBLASTOMA BIOPSIES DESPITE CHEMOTHERAPY: IMPLICATIONS FOR IMMUNE EVASION
Neuro-Oncology·2025Open Access
AAV9-mediated <i>KCNH2</i> suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome
European Heart Journal·2025· 2 citedOpen Access
Synaptic and intrinsic plasticity mediated by CCK-type signaling coordinates behavioral changes during motivational state shifts
Cell Reports·2025· 3 citedOpen Access
Induced Proteinuria Enhances Adeno-Associated Virus Transduction of Renal Tubule Epithelial Cells After Intravenous Administration
2025· 1 citedOpen Access
Development of a Pentacistronic Ebola Virus Minigenome System
Viruses·2025· 1 citedOpen Access
Convergent effects of peptides on the initiation of feeding motor programs in the mollusk <i>Aplysia</i>
Journal of Neurophysiology·2025· 1 citedOpen Access
PO-CES-04 KCNH2 SUPPRESSION-REPLACEMENT GENE THERAPY FOR TYPE 1 SHORT QT SYNDROME (SQT1): A PROOF-OF-CONCEPT EFFICACY TRIAL IN RABBITS WITH SQT1
Heart Rhythm·2025
BS-495073-003 KCNH2 SUPPRESSION-REPLACEMENT GENE THERAPY FOR TYPE 1 SHORT QT SYNDROME (SQT1): A PROOF-OF-CONCEPT EFFICACY TRIAL IN RABBITS WITH SQT1
Heart Rhythm·2025
ACE2 deficiency protects against heme protein-induced acute kidney injury
American Journal of Physiology-Renal Physiology·2025· 1 citedOpen Access
Reducing off-target expression of mRNA therapeutics and vaccines in the liver with microRNA binding sites
Molecular Therapy — Methods & Clinical Development·2024· 18 citedOpen Access
Renal phenotyping in a hypomorphic murine model of propionic aciduria reveals common pathomechanisms in organic acidurias
Scientific Reports·2024Open Access
page 1 of 15Next →

Frequent Co-authors

Alan Eastman(8), Sean Hofherr(6), Elena V. Shashkova(5), Eric A. Weaver(5), Antonios G. Mikos(4), Samuel K. Campos(4), Reeti Khare(4), Stephen Albert Johnston(3), Hoyin Mok(3), Donna Palmer(3), Philip Ng(3), M Brandon Parrott(3), Shannon M. May(3), D. M. Flynn(2), Kristen E. Adams(2), Mary E. Barry(2), George T. Mercier(2), Konstantin Doronin(2), Julien S. Senac(2), Jeremy S. Blum(2)